Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.24), may note compare the analyst estimate of ($0.23). Revenue for the quarter came in at $28.9 million versus the consensus estimate of $32.3 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Sanuwave Q2 2026 revenue tops revised guidance range
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings